The Food and Drug Administration has categorized Smiths Medical’s correction of more than 50,000 syringe pumps in the U.S. as a Class I recall. Smiths Medical, which became part of ICU Medical in a $2 ...
Smiths Medical has warned customers of more than 135,000 Medfusion syringe pumps about problems associated with earlier software versions. On March 5, the FDA posted an alert for 85,961 Medfusion ...
The U.S. Food and Drug Administration (FDA) this week issued a Class I recall — its most serious — for the Medfusion syringe pump, the agency’s third major recall of the line of devices made in ...
Syringe Pumps Market · GlobeNewswire Inc. Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The "Syringe Pumps Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. The ...
LONDON--(BUSINESS WIRE)--The global smart syringe pumps market is expected to post a CAGR of nearly 9% during the forecast period 2019-2023, according to the latest market research report by Technavio ...
Smiths Medical notified customers of 50,743 syringe pumps of a software issue that can cause serious injury or death, the FDA said Feb. 14. An earlier software version of the product, the Medfusion ...
Smiths Medical Inc., of Minneapolis, has undertaken a recall of its Medfusion 3500 and 4000 series of syringe infusion pumps because of software issues that could lead to over- or under-infusion of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback